Weill Cornell Medicine (WCM) neurosurgeons are committed to collaboration with fellow neuroscientists performing translational research, as the infusion of drugs and growth factors hold great promise for neurological disease patients. In addition, new technology using stem cell biology for the treatment of many neurological disorders, including strokes and brain tumors, may provide therapeutic options for our patient population. Our department plays a leading role in the implementation of these new neurological disease treatment paradigms.